Pressure Ulcers Treatment Market – By Product, By Ulcer Stage, By Type, By Age Group, By End Use - Global Forecast, 2025 – 2034

Pressure Ulcers Treatment Market Size

The pressure ulcers treatment market was valued at USD 7.4 billion in 2024. The market is expected to grow from USD 7.8 billion in 2025 to USD 13.1 billion in 2034, at a CAGR of 5.9%. The market growth is primarily driven by growing ageing demographics who are vulnerable to high incidence of pressure ulcer due to reduced mobility.
 

Also, increasing incidence of chronic conditions such as diabetes, and obesity caused due to sedentary lifestyle contributes to impaired wound healing. This is fueling demand for effective treatment solutions, thereby bolstering market growth.
 

Technological advancements in wound care, including biological skin substitutes, negative pressure wound therapy (NPWT), and smart dressings are providing enhanced clinical outcomes with quicker healing. These innovations are gaining traction across hospital and homecare settings. Increasing awareness for early diagnosis and prevention measures are leading to higher adoption of advanced wound care products. Further, supportive government initiatives, especially in developed regions, are encouraging the use of modern therapies. These factors collectively contribute to the market growth.
 

Pressure ulcers treatment refers to medical aid and therapeutic interventions aimed at preventing, managing, and healing pressure ulcers, also known as bedsores or decubitus ulcers. These ulcers are often caused due to prolonged pressure on the skin, often affecting the patients with less mobility. The aim of medical intervention is to reduce pressure, promoting healing, preventing infection and improving the clinical outcome. The treatment includes wound dressings, therapy devices, biologics, and other treatment options.
 

Pressure Ulcers Treatment Market Trends

• Significant advancement in wound care technologies is fueling the robust growth in pressure ulcers treatment market. The growing focus on advancing the treatment for chronic wound management including burden of pressure ulcers has exemplified the advancements in wound therapy products such as introduction of biologics coupled with advances in NPWT, skin substitutes, and sensor-equipped dressings.
   
• These medical solutions are inclined to deliver superior moisture management, reduce infection risks, and enable continuous monitoring of chronic wounds, including pressure ulcers.
   
• Also, the growing adoption of patient-centric treatments, the incorporation of bioactive dressings, and hyperbaric oxygen therapy has gained popularity in industry.
   
• Emerging technologies such as artificial intelligence (AI) enabling remote patient monitoring and customized treatment protocols have become increasingly crucial, particularly for patients with mobility challenges. For example, Bayesian's platform employs AI to evaluate electronic medical records (EMRs) and identify patients with high risk of ulcer pressure development. Thus, advancement aimed to expand the opportunities for AI in the industry.
   
• As healthcare facilities adopt advanced treatment methods to improve patient outcomes, the pressure ulcer treatment market shows strong growth potential.
   
• Further, better awareness among medical professionals, increased investment in research and development, and a growing focus on preventive care are a few other factors that are expected to drive continued expansion in the coming years.
   

Pressure Ulcers Treatment Market Analysis

In 2021, the global pressure ulcers treatment market was valued at USD 6.3 billion. The following year, it saw a slight increase to USD 6.7 billion and in 2023, the market climbed to USD 7 billion and is estimated to reach USD 7.4 billion in 2024.
 

Based on product, the global pressure ulcers treatment market is segmented into wound care dressings, biologics, wound therapy devices, medications, and other products. The wound therapy devices segment dominated the market and was valued at USD 3.3 billion in 2024 and is poised to reach USD 5.7 billion by 2034 at a CAGR of 5.7%.
 

• The wound therapy devices segment is further classified into negative pressure wound therapy (NPWT), hyperbaric oxygen therapy, and other wound therapy devices. These devices demonstrate significant acceleration in wound healing, infection prevention, and overall patient recovery which is gaining popularity in the industry.
   
• For example, NPWT systems illustrated substantial adoption rates due to their effectiveness in tissue regeneration and wound drainage management. Thus, the intensifying recognition of these advanced devices through reduced hospitalization periods and decreased complication rates, make them an essential components of modern wound care protocols.
   
• Additionally, recent developments in wound monitoring capabilities and automated pressure management systems have improved treatment precision and patient comfort. These advancements coupled with growing clinical requirements, reinforce the wound therapy devices segment's substantial market presence.
   

Based on ulcer stage, the global pressure ulcers treatment market is categorized into stage 1, stage 2, stage 3 and stage 4. The stage 2 segment accounted for the highest market share of 36.3% in 2024 and is poised to grow at a substantial rate during the analysis period.
 

• The frequent occurrence and intermediate severity levels of stage 2 ulcers boosts the demand for effective treatment. These ulcers are characterized by partial-thick skin damage appearing like blisters or shallow wounds, commonly affecting the patients with limited mobility in hospitals and long-term care facilities.
   
• The common treatment protocols include the use of specialized dressings, such as hydrocolloids, foam, and hydrogel products, which combine effectiveness with reasonable costs and wide availability.
   
• Further, the emphasis on early intervention at stage 2 supports preventing the development of more severe pressure ulcers, making it a key focus area for healthcare providers. This clinical importance, combined with treatment accessibility, reinforces Stage 2's dominant position in the pressure ulcer treatment market.
   

Based on the type, the global pressure ulcers treatment market is categorized into over-the-counter (OTC) and prescription. In 2024, the prescription segment accounted for the highest revenue and is anticipated to reach USD 3.5 billion by 2034.
 

• The prescription product prominence was asserted due to the effectiveness and clinical necessity of prescribed medications and therapies. These include advanced wound dressings, topical agents, and systemic treatments recommended by healthcare professionals.
   
• Patients with severe or chronic ulcers often require prescription-based care, thereby driving consistent demand.
   
• Regulatory approvals and insurance coverage for surgical interventions and treatment further support market growth.
   
• As healthcare providers prioritize evidence-based treatment plans, the prescription segment continues to dominate, reflecting its critical role in improving patient outcomes and supporting long-term wound management strategies.
   

Based on the age group, the global pressure ulcers treatment market is categorized into pediatric, adult, and geriatric. In 2024, the geriatric segment accounted for the largest share of 50% in the market and is anticipated to dominate the market throughout the forecast period at a CAGR of 5.7%.
 

• The geriatric segment prominence was asserted to increased age-related risk factors in this demographic group such as reduced mobility, chronic disease, and impaired skin integrity.
   
• Elderly population, particularly those in hospitals and long-term care settings, experience higher incidence rates, driving demand for advanced wound care products and services.
   
• In addition, with the global aging population steadily rising, healthcare providers are prioritizing prevention and treatment strategies for this demographic. This trend significantly contributes to market growth, thus positioning the geriatric segment as a key driver in the pressure ulcer management industry.
   

Based on the end use, the global pressure ulcers treatment market is categorized by hospitals, ambulatory surgical centers (ASCs), specialty clinics, and other end users. In 2024, the hospitals segment accounted for the largest share of 43.8% in the market and is anticipated to reach USD 5.5 billion by 2034.
 

• The hospital segment dominance was driven due to its well-developed infrastructure, high throughput of patients, and the presence of specialized units for wound care management.
   
• Hospitals are preferred as the first referral centers for managing the severe disease symptoms including the chronic wounds. Also, the availability of skilled personnel and multidisciplinary personnel supports hospitals to proficiently manage chronic diseases.
   
• Therefore, pressure ulcers treatment is preferred in hospital settings due to specialized podiatry clinics and advanced complex case management capabilities.
   

In 2024, North America accounted for the largest revenue of USD 2.9 billion and is projected to generate revenue of USD 5 billion by 2034 at a CAGR of 5.5% during the analysis period.
 

• The regional prominence was due to robust healthcare infrastructure, high awareness level and the widespread adoption of advanced wound care technologies. Also, growing R&D efforts with significant investment encourage the adoption of advanced therapies for wound management.
   
• The high prevalence of chronic conditions such as diabetes, and obesity along with the growing aging population that are more prone to high incidence of sores significantly prompting the need for effective treatment. Furthermore, the presence of leading companies contributes to market growth.
   

In 2024, the U.S. pressure ulcers treatment market accounted for USD 2.7 billion revenue from USD 2.5 billion in 2023.
 

• The U.S. leadership was asserted due to advanced healthcare facilities, high incidence of chronic wound and substantial funding in wound management solutions.
   
• According to a study published in Nation Institute of Health, 1 in 3 people in U.S. suffer from pressure injuries projecting a persistent source of morbidity. The recurrence of the incidence may result in treatment complexity and economic burden accounting for nearly USD 26.8 billion annually. This includes costs for hospital care, long-term care facilities, and other settings.
   
• Growing government initiatives and increasing clinical research activities further strengthen the demand for treatment. For instance, Open Wound Research and Venture Medical, LLC have entered into a collaborative research agreement to advance the study of pressure ulcer treatment. As part of this partnership, Venture Medical has acquired extensive pressure ulcer data from Open Wound Research to evaluate the efficacy of CAMPS in comparison to standard of care (SOC) treatments.
   
• Thus, the aforementioned factors set the U.S. the foremost contributor to North America’s position as the dominant region.
   

Germany is poised to achieve significant growth in the Europe pressure ulcers treatment market.
 

• Germany growth stemmed from its larger geriatric population, and innovation in wound care technology.
   
• The country has seen a surge in demand for advanced wound care products, including biologics and negative pressure wound therapy devices, as healthcare providers prioritize early intervention and effective treatment strategies.
   
• In addition, growing government initiatives to promote chronic wound care, along with favorable reimbursement policies for treatment support the market expansion.
   
• Moreover, Germany's established network of medical device manufacturers and research institutions promotes innovation and supports the implementation of advanced technologies, thereby continuing to maintain its leadership in the Europe’s pressure ulcers treatment market.
   

Asia Pacific is poised to grow at a significant growth rate in the global pressure ulcers treatment market over the next few years.
 

• The Asia Pacific region exhibits substantial growth driven by growing healthcare spending, and the awareness of advanced wound care solutions. The region is experiencing rapid increase in its elderly population particularly in the countries such as China, Japan, India and South Korea where ageing related mobility and chronic condition contributes to rising pressure ulcers incidence.
   
• These rising cases are expected to spur the need for effective treatment options such as biologics, wound dressing and wound therapy devices.
   
• Furthermore, growing governments and private healthcare investments in advanced wound care technologies, including NPWT and biologics is expected to fuel the adoption. For example, HCAH are implementing specialized wound care programs through collaborations with global partners, emphasizing preventive and home-based care.
   

China is anticipated to grow significantly within the Asia Pacific pressure ulcers treatment market.
 

• China is set for considerable growth attributed to the expanding ageing demographic, increasing awareness for chronic wound care management, coupled with bolstered access to advanced wound care solutions. According to a multicenter, cross-sectional, exploratory descriptive study in China, the pressure injuries prevalence was 3.38%, and the PI cumulative incidence was 1.23%.
   
• Government initiatives such as “Healthy China 2030” are likely to spur innovation and accessibility to chronic wound care in China.
   
• Also, pharmaceutical and biotechnology companies continue to make substantial investments in biologics development, coupled with the efforts to enhance the regulatory support has streamlined approval processes, contributing to the expansion of the biologics market.
   
• These developments, coupled with the growing public health expenditures, expansion of hospitals, and increased spending is expected to augment China’s position in the Asia Pacific pressure ulcers treatment market.
   

Brazil is projected to witness significant growth in Latin America pressure ulcers treatment market in coming years.
 

• The expanding proportion of elderly population coupled with increasing prevalence of chronic disease, yearly incidences of skin sores and a constant improvement in the healthcare facilities are expected to aid in the growth.
   
• Recent studies have shown that pressure ulcers are a significant problem in Brazil, and several local and international organizations have recognized the important role nurses play in prevention and care. The prevalence of pressure ulcers was 16.9%.
   
• As a result, nursing education and resources have improved and evaluating the risk and occurrence of pressure ulcers has become a method of establishing indicators of quality care in Brazil.
   

Saudi Arabia is anticipated to grow in the Middle East and Africa pressure ulcers treatment market.
 

• Saudi Arabia is set to show prominent growth driven by the increasing spending in healthcare infrastructure, growing elderly population vulnerable to pressure ulcer and rising awareness for chronic wound management solutions.
   
• Also, the growing government initiative towards strengthening healthcare services such as Vision 2030, which aims to modernize healthcare systems, foster the adoption of advanced wound care technologies, including negative pressure wound therapy and biologics.
   
• Moreover, the expansion of private healthcare providers and the rising demand for homecare solutions are contributing to the market’s momentum.
   
• The expanding global and regional healthcare companies into the country further strengthens Saudi Arabia position in the Middle East and Africa market.
   

Pressure Ulcers Treatment Market Share

The top 5 players in the global pressure ulcers treatment market accounted for ~25% of the share. The market remains moderately fragmented, with established companies such as Smith+Nephew, ConvaTec Group, 3M Health Care, B. Braun and Molnlycke Health Care holding substantial market shares through their extensive wound care product portfolios. The leadership is primarily driven by the cutting-edge innovation, product diversification, and global expansion efforts implemented by the key players investing in wound care management solutions including superabsorber dressings, extracellular matrix therapies, and negative pressure wound therapy systems.
 

The emerging companies are gaining traction by focusing on specialized biologics and customized wound care solutions. Furthermore, strategic partnerships, regulatory approvals, geographic expansion are the key competitive strategies adopted by the key players in the competitive market.
 

Pressure Ulcers Treatment Market Companies

Few of the prominent players operating in the pressure ulcers treatment industry include:

• 3M Healthcare
• AHA Hyperbarics
• Integra LifeSciences
• Ascend Laboratories
• B. Braun
• Baxter
• BioTissue
• Cardinal Health
• Coloplast
• Convatec
• Ethicon (Johnson and Johnson)
• GlaxoSmithKline (GSK)
• Ipca Laboratories
• LifeNet Health
• Medline
• MIMEDX
• Molnlycke Health Care
• Organogenesis
• Pfizer
• Smith & Nephew
• StimLabs
• Zimmer Biomet

• Smith & Nephew is one of the leading players in the market with cutting-edge wound care products like its NPWT systems and ALLEVYN foam dressings. Its strong worldwide distribution network, emphasis on evidence-based innovation, and wide range of wound management products contribute to its dominance of the market.

• Molnlycke is well known for its Mepilex dressings, that are frequently used to treat and prevent pressure ulcers. The company offers superior wound care outcomes through patient-centered, research-backed products in hospitals and long-term care facilities, emphasizing gentle silicone technology, clinical efficacy, and sustainability.

• Convatec provides a wide selection of cutting-edge skin care and wound care products. Convatec is a major pioneer in the treatment of pressure ulcers due to its AQUACEL line, which is reliable across worldwide for controlling exudate and encouraging healing for its Hydrofiber technology.
   

Pressure Ulcers Treatment Industry News

• In April 2025, Tidewave Medical introduced the first continuous movement system Tidewave, a pressure care solution. This pressure care mattress allows the continuous movement of patients in harmony with the support surface. The rhythmic lateral repositioning aimed to relieve the pressure without disruption promoting both prevention and healing including high-risk in patient with immobility till Stage 4 patient. The introduction of such assistive technology aimed to offer an effective approach towards pressure ulcer treatment.
   
• In September 2024, HCAH introduced a strategic initiative to enhance wound care and promote patient recovery in collaboration with Aroa Biosurgery. The company's "WOW (Warriors of Woundcare) Nurses" program, aimed at preventing and treating pressure ulcers in patients with limited mobility, is a key component of this endeavor. The aim of this cooperative effort was to increase the use of preventive measures for wound care management.
   
• In April 2024, Smith + Nephew introduced its RENASYS EDGE, a NPWT system in U.S. This patient-centric solution was introduced to cater to the burden of chronic wound including the pressure ulcers. This introduction marked an advancement in the wound care management sector.
   

The pressure ulcers treatment market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Wound care dressings        
  • Alginate dressings
  • Foam dressings
  • Hydrocolloid dressings
  • Hydrogel dressings
  • Film dressings
  • Other wound care dressings
• Biologics
  • Skin substitutes
  • Growth factors
  • Other biologics
• Wound therapy devices      
  • Negative pressure wound therapy
  • Hyperbaric oxygen therapy
  • Other wound therapy devices
• Medications
• Other product

Market, By Ulcer Stage

• Stage 1
• Stage 2
• Stage 3
• Stage 4

Market, By Type

• Over-the-counter (OTC)
• Prescription

Market, By Age Group

• Pediatric
• Adult
• Geriatric

Market, By End Use

• Hospitals
• Ambulatory surgical centers (ASCs)
• Specialty clinics
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE